Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy

Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy

Abstract Background Nintedanib is an inhibitor of receptor tyrosine kinases, including vascular endothelial growth factor receptor, but its effects on pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF) patients with chronic hypoxia were unclear. Methods This study included a nintedan...

Full description

Bibliographic Details
Main Authors: Masahiro Tahara, Keishi Oda, Kei Yamasaki, Takako Kawaguchi, Konomi Sennari, Shingo Noguchi, Noriho Sakamoto, Toshinori Kawanami, Hiroshi Mukae, Kazuhiro Yatera
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Pulmonary Medicine
Subjects:
Echocardiography
Idiopathic pulmonary fibrosis
Long-term oxygen therapy
Nintedanib
Pulmonary hypertension
Online Access:http://link.springer.com/article/10.1186/s12890-019-0918-3

Internet

http://link.springer.com/article/10.1186/s12890-019-0918-3

Similar Items